Yearly Archives: 2024

Pharmacy owners are reminded that from 1st April 2024,  they must have an otoscope available, and all clinical pathways must be provided in bricks and mortar* pharmacies registered to provide the Pharmacy First service. This deadline was highlighted in the NHS England letter announcing the Pharmacy First service, which advised that pharmacy owners could start [...]

The post Pharmacy First: Requirement to have an otoscope from 1st April appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Semaglutide (Ozempic®) 0.25mg, 0.5mg and 1mg solution for injection in a pre-filled pen Dulaglutide (Trulicity®) 0.75mg, 1.5mg, 3mg and 4.5mg solution for injection in a prefilled pen Liraglutide (Victoza®) 6mg/ml solution for injection in a pre-filled pen. MSN/2024/031 Tier 3 – [...]

The post Medicine Supply Notification: Supply issues with multiple GLP-1 RA products appeared first on Community Pharmacy England.

As announced in the NHS Primary Care bulletin (published 14 March 2023), over half of GP surgeries have digital solutions available to automate the issuing of listed HRT items as single-item prescriptions at the point of prescribing (separate prescriptions for each HRT item). This is something  that NHS England and Department of Health and Social Care [...]

The post HRT prescribing for PPCs – GP IT update appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (15/03/2024) announced the following initial list of price concessions for March 2024: Drug  Pack size Price concession Amiodarone 200mg tablets 28 £1.83 Aripiprazole 10mg tablets 28 £7.89 Aripiprazole [...]

The post March 2024 Price Concessions 1st Update appeared first on Community Pharmacy England.

The Lateral flow device tests supply service for patients potentially eligible for COVID-19 treatments (LFD service) will continue to be commissioned as an Advanced service in 2024/25. In addition, from 1st April 2024, the following additional patient groups will be eligible to access the LFD service, as well as those previously eligible for the service: [...]

The post LFD service: New eligible patient groups from 1st April appeared first on Community Pharmacy England.